Other Useful Information > Letters to Trade

Letters to Trade   Saxagliptin- FDA to Review Heart Failure Risk (Letter to Healthcare Professionals)       Attachment: Saxagliptin- FDA to Review Heart Failure Risk.pdf   Related Information: The United States: FDA Drug Safety Communication: FDA adds warnings about heart ... Posted 2016-04-06 Type 2 diabetes medicines containing saxagliptin and alogliptin: risk of heart f... Posted 2016-04-06 The United States: Saxagliptin (marketed as Onglyza and Kombiglyze XR): Drug Saf... Posted 2014-02-12